One of the biggest gatherings of clinicians and researchers practicing in the areas of lymphoma and transplantation, the 2021 Pan Pacific Lymphoma Conference took place August 9–13 in Hawaii. The conference, which was organized by the University of Nebraska Medical Center, offered participants an opportunity to examine vital information on clinical updates and research, meet key thought leaders, and share ideas with more than 500 members of the multidisciplinary lymphoma clinical team—including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists. Highlights included the presentation of the James O. Armitage Lymphoma Clinical Investigator Award and delivery of the Oliver Press Memorial Lecture.
The James O. Armitage Lymphoma Clinical Investigator Award
Loretta J. Nastoupil, MD
Loretta J. Nastoupil, MD, was honored with The James O. Armitage Lymphoma Clinical Investigator Award. Dr. Nastoupil is Associate Professor, Director of the Lymphoma Outcomes Database, and Section Chief of New Drug Development in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center.
This award recognizes lymphoma clinical investigators who have moved the field to the next level with their design and involvement in lymphoma clinical trials. It is named for James Armitage, MD, FASCO, who has devoted his life to clinical care and research in the lymphoma field. The first award was given in 2018 to Matthew Davids, MD, MMSc.
Oliver Press Memorial Lecture
Ranjana H. Advani, MD
The Oliver Press Memorial Lecture honors an experienced lymphoma clinical investigator who has made significant contributions to the clinical and translational research in lymphoma. This year’s lecture, “Historical Development of Hodgkin Therapy at Stanford,” was delivered by Ranjana H. Advani, MD. Dr. Advani is the Saul Rosenberg Professor of Lymphoma and serves as the Physician Leader of Stanford’s Lymphoma Clinical Care Program.
This award is named for Oliver Press, MD, PhD, who was an experienced translational and clinical scientist and contributed significantly to the field of lymphoma research and care. The first award was given in 2018 to David Maloney, MD, PhD, for his translational research in the field of non-Hodgkin lymphoma.
